'It's a ticking time bomb': Acid levels in Earth's oceans have already breached 'danger zone', study suggests
Earth's oceans are in worse condition than scientists thought, with acidity levels so high that our seas may have entered a "danger zone" five years ago, according to a new study.
Humans are inadvertently making the oceans more acidic by releasing carbon dioxide (CO2) through industrial activities such as the burning of fossil fuels. This ocean acidification damages marine ecosystems and threatens human coastal communities that depend on healthy waters for their livelihoods.
Previous research suggested that Earth's oceans were approaching a planetary boundary, or "danger zone," for ocean acidification. Now, in a new study published Monday (June 9) in the journal Global Change Biology, researchers have found that the acidification is even more advanced than previously thought and that our oceans may have entered the danger zone in 2020.
The researchers concluded that by 2020, the average condition of our global oceans was in an uncertainty range of the ocean acidification boundary, so the safety limit may have already been breached. Conditions also appear to be worsening faster in deeper waters than at the surface, according to the study.
"Ocean acidification isn't just an environmental crisis — it's a ticking time bomb for marine ecosystems and coastal economies," Steve Widdicombe, director of science and deputy chief executive at Plymouth Marine Laboratory, a marine research organization involved in the new study, said in a statement. "As our seas increase in acidity, we're witnessing the loss of critical habitats that countless marine species depend on and this, in turn, has major societal and economic implications."
Related: Atlantic ocean currents are weakening — and it could make the climate in some regions unrecognizable
In 2009, researchers proposed nine planetary boundaries that we must avoid breaching to keep Earth healthy. These boundaries set limits for large-scale processes that affect the stability and resilience of our planet. For example, there are boundaries for dangerous levels of climate change, chemical pollution and ocean acidification, among others.
A 2023 study found that we had crossed six of the nine boundaries. The authors of that study didn't think the ocean acidification boundary had been breached at the time, but they noted it was at the margin of its boundary and worsening.
Katherine Richardson, a professor at the Globe Institute at the University of Copenhagen in Denmark who led the 2023 study and was not involved in the new study, told Live Science that she was "not at all surprised" by the new findings.
"We said it was on the edge in our last assessment and, as atmospheric CO2 concentrations have risen since then, it is hardly surprising that it should be transgressed now," Richardson said in an email.
Ocean acidification is mostly caused by the ocean absorbing CO2. The ocean takes up around 30% of CO2 in the atmosphere, so as human activities pump out CO2, they are forcing more of it into the oceans. CO2 dissolves in the ocean, creating carbonic acid and releasing hydrogen ions. Acidity levels are based on the number of hydrogen ions dissolved in water, so as the ocean absorbs more CO2, it becomes more acidic.
The hydrogen ions bond with carbonate ions in the ocean to form bicarbonate, which reduces the carbonate available to marine life like corals, clams and plankton. These animals need carbonate for their bones, shells and other natural structures, which they make out of calcium carbonate (CaCO3). Researchers measure aragonite — one of the soluble forms of CaCO3 — to track ocean acidity levels.
The ocean acidification boundary would be breached when the oceans see a 20% reduction of aragonite compared with preindustrial levels (estimated ocean acidification for 1750 and 1850). The 2023 study estimated that ocean acidification was at 19%, just below the boundary.
The authors of the new study used physical and chemical measurements in the upper ocean and computer models to update and refine previous ocean acidification estimates. They also introduced a margin of error, including uncertainties in both the boundary and the present-day acidification value.
RELATED STORIES
—Record-breaking piles of sargassum seaweed wash up on Caribbean beaches, with more on the way
—The Earth's oceans used to be green — and could one day turn purple, scientists say
—There's an acidic zone 13,000 feet beneath the ocean surface — and it's getting bigger
With the new data, the researchers found that at the ocean's surface, the global average acidification level is 17.3% (with a 5% margin of uncertainty) less than preindustrial levels. That estimate is lower than the 2023 estimate but well within the new study's wider boundary region (20% but with a 5.3% margin of uncertainty). The newly estimated acidification levels increased at greater depths, though the margin for error also increased below 330 feet (100 meters), according to the study's data.
Not all of the ocean is acidifying at the same rate. For example, the researchers determined that about 40% of the water at the surface had crossed the boundary, but that estimate rose to 60% for the waters below, down to about 650 feet (200 m).
"Most ocean life doesn't just live at the surface — the waters below are home to many more different types of plants and animals," study lead author Helen Findlay, a biological oceanographer at the Plymouth Marine Laboratory, said in the statement. "Since these deeper waters are changing so much, the impacts of ocean acidification could be far worse than we thought."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
43 minutes ago
- Associated Press
Italy's Ventina glacier has melted so much geologists now can only monitor it remotely
ROME (AP) — Italy's Ventina glacier, one of the biggest in northern Lombardy, has melted so much due to climate change that geologists can no longer measure it the way they have for the past 130 years. After this year's hot summer, geologists discovered that the simple stakes used as benchmarks to measure the glacier's retraction each year are now buried under rockslides and debris that have made the terrain too unsteady for future in-person visits. The Lombardy Glaciological Service said Monday that it will now use drone imagery and remote sensing to keep track of the ongoing shrinkage. Geologists say that the Ventina glacier has already lost 1.7 kilometers (1 mile) in length since the first measuring benchmarks were positioned at the front of the glacier in 1895. The melting has accelerated in recent years, with the glacier losing 431 meters (471 yards) in the last 10 years, nearly half of that since 2021, the service said. It's another example of how accelerating global warming is melting and shrinking Europe's glaciers, causing a host of environmental and other impacts. 'While we could still hope until the 1980s that there would be normal cycles (of retraction) or at least a contained retraction, in the last 40 years something truly striking has occurred,' said Andrea Toffaletti, a member of the Lombardy Glaciological Service. Italy's mountain glaciers, which are found throughout the Alps and Dolomites in the north and along the central Apennines, have been receding for years, thanks to inadequate snowfall in the winter and record-setting hot summers. Glaciers always melt some in summer, with the runoff fueling mountain streams and rivers. But the hot summers are 'no longer able to guarantee the survival of the winter snowpack,' that keeps the glacier intact, Toffaletti said. 'In order to regenerate and remain in balance, a certain amount of residual snow from the winter must remain on the glacier's surface at the end of the summer. And this is happening less and less frequently,' said Toffaletti. According to the Lombardy service, the Alps represent a climate hotspot, recording double the global average of temperature increases since pre-industrial times, resulting in the loss of over 64% of the volume of Alpine glaciers. In February, the journal Nature reported on a study showing the world's glaciers lost ice at the rate of about 255 billion tons (231 billion metric tons) annually from 2000 to 2011, but that quickened to about 346 billion tons (314 billion metric tons) annually over about the next decade.
Yahoo
3 hours ago
- Yahoo
Is This Space Stock the Next Big Trillion-Dollar Opportunity?
The race to dominate space is no longer limited to just exploration, but is also about securing tomorrow's infrastructure and defense systems. Among the most ambitious players, Rocket Lab (RKLB) is emerging as one of the most compelling space companies. Rocket Lab stock has soared 604.6% over the past year. So far this year, the stock has captured attention, rising 81.5%, wildly outperforming the broader market gain. More News from Barchart Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Cathie Wood Is Buying BLSH Stock After the Bullish IPO. Should You? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. The global space economy is estimated to be worth $1.8 trillion by 2035. With record revenues, expanding contracts with space agencies and the U.S. Department of Defense, and its upcoming Neutron rocket program, the company is making a strong case that it could be a leading player in the next trillion-dollar opportunity in space. Let's find out if RKLB stock is a buy now. About Rocket Labs Valued at $20.4 billion, Rocket Lab specializes in launch services, spacecraft manufacturing, and satellite solutions. The company is best known for its Electron rocket, a small-lift launch vehicle used to place small satellites in orbit. It has a lifting capacity of about 300 kilograms. Electron is one of the most frequently launched U.S. rockets after Elon Musk-owned SpaceX's Falcon 9, mainly serving the small satellite market. To compete more directly with SpaceX, the company is developing Neutron, a larger rocket designed for medium-class payloads and potentially reusable launch systems. The company also manufactures spacecraft platforms and components, which are not only used in Rocket Lab missions, but also sold to other aerospace and defense firms. This diversification is critical because the satellite market and defense-related contracts generate recurring, high-margin revenue streams in contrast to the capital-intensive launch business. Rocket Lab Is Soaring High In the second quarter, total revenue came in at $144.5 million, a 36% year-over-year increase. Space Systems delivered $97.9 million in revenue driven by rising demand for satellite components and manufacturing. Launch Services generated $66.6 million, indicating strong demand for Electron launches and early pipeline momentum for Neutron and the hypersonic-testing HASTE program. Importantly, Rocket Lab ended Q2 with $1 billion in backlog, demonstrating its robust order pipeline. Management anticipates that approximately 58% of this backlog will be converted to revenue within the next 12 months, providing the company with visibility into near-term growth. With 70 launches completed, Electron has shown dependability that competitors in the small-launch market struggle to match. While Electron is Rocket Lab's present, Neutron is its future. Neutron, designed as a reusable medium-lift rocket, will compete directly with SpaceX's Falcon 9 for commercial and national security missions. The company anticipates receiving Neutron's first launch license by the end of this year. During the Q2 earnings call, management emphasized that Rocket Lab is not simply building one rocket. Instead, it is investing in scalable infrastructure to accommodate multiple Neutron flights each year. The company intends to produce three Neutrons per year beginning next year, thanks to automated composite manufacturing and long-lead equipment orders. If successful, Neutron could help Rocket Lab capture a much larger share of the more than $100 billion global launch services market. Furthermore, one of Rocket Lab's boldest moves this year has been the acquisition of GEOST, a leading manufacturer of space-based missile tracking satellites. This agreement solidifies Rocket Lab's strategy of vertical integration, from launch to spacecraft and now payloads. This establishes the company as a one-stop shop for national security operations. Rocket Lab's ambitions go far beyond Earth orbit. The company has been heavily involved in Mars exploration, providing components for missions such as NASA's InSight lander, the Perseverance rover's cruise stage, and the Ingenuity helicopter. The company remains unprofitable due to high R&D costs. Net losses came in at $0.13 per share, while adjusted EBITDA losses reached $27.6 million. At the end of the second quarter, liquidity remained strong at $754 million in cash, cash equivalents, restricted cash, and marketable securities. Despite the tremendous opportunities, risks persist. A slip in Neutron's launch schedule could dampen momentum and test investor patience. Rocket Lab must deliver on time, at scale, and with unwavering reliability. Looking ahead, management anticipates Q3 revenue to be between $145 million and $155 million. Adjusted gross margins could reach 39% to 41%, indicating improved launch economics and overhead absorption. Adjusted EBITDA loss is expected to narrow to between $21 million and $23 million, highlighting the company's progress toward profitability as R&D spending shifts from development to recurring flight operations. Analysts covering Rocket Lab stock predict that revenue will increase by 34.6% in 2025, followed by a 52.6% increase in 2026. Analysts anticipate that losses will gradually decrease by next year. Trading at 36 times forward sales, Rocket Lab's stock is steep, but it reflects investors' high expectations. What Does Wall Street Say About Rocket Lab Stock? Overall, Wall Street rates Rocket Lab stock a 'Moderate Buy.' Of the 15 analysts who cover the stock, eight rate it as a 'Strong Buy,' one says it is a 'Moderate Buy,' while the remaining six rate it a 'Hold.' The stock has surpassed its average target price of $43.85. But its high target price of $55 implies a 22% increase from current levels. The Key Takeaway Given the financial momentum, a billion-dollar backlog, and strong liquidity, if Rocket Lab executes on its strategy, it could emerge as a key player in the next wave of the space industry, which could be worth trillions within the next decade. While Rocket Lab is an intriguing growth stock, risk-averse investors may want to wait until the company generates a profit before making any investment decisions. On the date of publication, Sushree Mohanty did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
6 hours ago
- Yahoo
Accelerating diagnosis and drug development with better managed datasets
Every aspect of science and research is based on data, and across the globe, labs are producing more data than the average person can even comprehend. With the increasing digitalisation of research, facilities are experiencing steady growth in data volumes, bringing with it a need for scalable storage solutions. A Laboratory Information Management System (LIMS) is software used by laboratories to create a central repository for storing, managing and accessing data. As well as storing all essential data relating to samples and results, a LIMS can automate digital processes. This helps labs to optimise workflows, minimise human error, and efficiently analyse large amounts of complex data. The result? Faster diagnosis times and development of new drugs. Managing research and clinical data Data is one of the most prized and valuable assets of a pharma, biotech, research or clinical laboratory. Therefore, the system used to collect, manage and analyse that data needs to be extremely robust, offering secure storage and flexible reporting capabilities. It's also important to be able to accurately analyse and manage samples, enabling the lab to carry out its core functions. Historically, laboratories used spreadsheets to manage data and reporting. This is simply no longer sufficient to meet the demands of modern laboratories; as well as being complicated, it's time-consuming and prone to error. When labs are dealing with the personal data of hundreds of thousands of patients, it's vital these standards are met. Whilst data management systems exist in all industries, implementing one that is specifically designed for use by labs helps to ensure the immediate availability of all necessary data and security functions. LIMS solutions can handle the large volumes of data created by labs while being reliable and scalable to cope with changing output requirements. They also offer versatile tools with automation capabilities for data monitoring, analysis and reporting. Benefits of a LIMS The main purpose of a LIMS is to improve data efficiency and accuracy by reducing manual operations. It does this by managing large volumes of data quickly and efficiently whilst maintaining strict industry standards for laboratory data management. Not only that, LIMS enables the automation of complex data analysis, reducing the need for repetitive lab data tasks, freeing up the time of skilled scientists for more skilled tasks. An efficient LIMS can integrate seamlessly with other essential systems, which is vital for a lab to run smoothly. The best piece of equipment is useless to clinicians if it cannot be used in conjunction with other necessary technology. Critically, a LIMS creates a single point of access to ensure data consistency, improving overall data quality and security across an organisation. What is LIMS used for? Some of the most common tasks supported by LIMS are: Sample management: Modern labs often deal with huge numbers of samples that need to be analysed, and manual processes are susceptible to errors and delays. LIMS solutions help to track and trace individual samples by generating a barcode that technicians, at various stages of testing and analysis, can scan to retrieve existing details or record additional information. Workflow management: High-quality, traceable results are essential to the success of any lab. By combining all your data in a single location that integrates with a wider network of collaborators, a LIMS empowers laboratories to better manage workflows, improve communication and increase outputs. Materials management: Lab processing relies heavily on tracking materials used, typically reagents. A LIMS enables detailed monitoring of inventoried reagents, how much is on hand, lot numbers, expiration dates and reorder levels. Traditional stock management systems are designed for simple warehousing and distribution applications but aren't able to keep up with the complex laboratory environment. A LIMS allows for complete visibility of the entire lab, including fridges, multiple lab locations and disposal bins, as well as recording where a particular reagent lot was used and with what samples it was combined. Inventory management: Laboratories are consistently under pressure to reduce their running costs while also maximising productivity. One of the most effective ways to do this is by improving inventory management, helping your lab to not only track resources but also to use them as efficiently as possible. The LIMS system supports the management of lab consumables, alerting you to low stock, preventing duplicate orders and managing shopping lists to minimise downtime and reduce costs. Request management portal: A LIMS supports wider collaboration by making it easy to request, send, and receive samples through the integrated request portal. Authorised researchers and physicians can then securely track and access samples to improve and extend your research team. Keeping up with an evolving landscape Just like the fast-paced industries that use them, laboratory information management systems are continually evolving. Digitalisation is having a major impact on biotech and pharma businesses managing research and clinical labs, especially when combining LIMS to manage lab operations, ELNs (Electronic Lab Notebooks) to document experimental processes, and SDMS (Scientific Data Management Systems) to handle data resulting from experiments. "Accelerating diagnosis and drug development with better managed datasets" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
